Persistence of neurological symptoms due to neuroleptic drugs.
D000328:Adult; D002746:Chlorpromazine / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced*; D010919:Placebos; D013997:Time Factors; D014149:Tranquilizing Agents / Q000009:adverse effects*
D010919:Placebos; D014149:Tranquilizing Agents; D002746:Chlorpromazine